Day: March 2, 2026

us corporate news

Zymeworks Inc. 2025 Annual Report: Business Overview, Strategy, Risk Factors, and Pipeline Highlights

Minichart

March 2, 2026

Zymeworks Inc. 2025 Annual Report: Key Highlights for Invest...

Continue Reading 0

us corporate news

Venture Global, Inc. 2025 Annual Report (Form 10-K): LNG Business, Financials, Key Risks, and Glossary of Terms

Minichart

March 2, 2026

Executive Summary Venture Global, Inc. (“the Company”), a...

Continue Reading 0

us corporate news

Biglari Holdings Inc. 2025 Annual Report: Business Overview, Risk Factors, and Financial Statements

Minichart

March 2, 2026

Biglari Holdings Inc. 2025 Annual Report: Key Investor Takea...

Continue Reading 0

us corporate news

Sarepta Therapeutics, Inc. 2025 Annual Report: SEC Form 10-K Filing, Financials, Risk Factors, and Business Overview

Minichart

March 2, 2026

Sarepta Therapeutics, Inc. Annual Report 2025: Key Highlight...

Continue Reading 0

us corporate news

GT Biopharma, Inc. 2025 Annual Report: TriKE® Immuno-Oncology Pipeline, Risks, Patents, and Business Overview

Minichart

March 2, 2026

GT Biopharma, Inc. 2025 Annual Report: Key Highlights and In...

Continue Reading 0

us corporate news

Geron Corporation 2025 Annual Report: RYTELO Commercialization, Risks, and Business Overview

Minichart

March 2, 2026

Company Overview Geron Corporation (Nasdaq: GERN) is now ...

Continue Reading 0

us corporate news

Steven Madden, Ltd. 2025 Annual Report: Business Overview, Brands, Segments, Risks, and Corporate Strategy 3436374148

Minichart

March 2, 2026

Steven Madden, Ltd. 2025 Annual Report Analysis: Key Investo...

Continue Reading 0

SGX Financial statements

Jawala Inc. Issues Profit Guidance for HY2026: Slight Increase in Net Loss Expected, No Dividend Details Announced

Minichart

March 2, 2026

Jawala Inc. HY2026 Profit Guidance: Financial Analysis and O...

Continue Reading 0

us corporate news

Sionna Therapeutics 2025 Annual Report: Clinical Pipeline, Risk Factors, Intellectual Property, and Business Overview

Minichart

March 2, 2026

Sionna Therapeutics, Inc. 2025 Annual Report: Key Financial ...

Continue Reading 0

SGX Financial statements

Hoe Leong Corporation Ltd. FY2025 Financial Results – Revenue Decline, Profit Review, No Dividend Declared

Minichart

March 2, 2026

Hoe Leong Corporation Ltd. FY2025 Financial Analysis: Naviga...

Continue Reading 0